Direkt zum Inhalt
Merck

LC/MS Analysis of 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 on Ascentis® Express F5

LC/MS Analysis of 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 on Ascentis® Express F5 application for HPLC

Materialien

Analytische Säule

Produkt-Nr.
Beschreibung
Preisangaben

Ascentis® Express F5, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

Standard

Produkt-Nr.
Beschreibung
Preisangaben

25-Hydroxyvitamin D3 -Lösung

100 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express F5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53569-U)

mobile phase

5 mM ammonium formate in methanol:water (75:25)

flow rate

0.4 mL/min

column temp.

40 °C

detector

UV, 265 nm (MS, ESI(+), m/z 100-1000)

injection

1 μL

sample

20 μg/mL in methanol

Beschreibung

Hinweis zur Analyse

The 25-OH forms of the secosteroids vitamin D2 and D3 are indicators of the vitamin D status of an individual. However, because they have different biological activity and clinical interest, they should be distinguishable. The Ascentis Express F5 phase was able to resolve the two compounds under highly LC-MS/MS compatible conditions. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany